𝔖 Bobbio Scriptorium
✦   LIBER   ✦

An assessment of immunoreactive epidermal growth factor in urine of patients with urological diseases

✍ Scribed by Chow, N. H. ;Tzai, T. -S. ;Cheng, P. -E. ;Chang, C. -J. ;Lin, J. S. -N. ;Tang, M. -J.


Publisher
Springer
Year
1994
Tongue
English
Weight
837 KB
Volume
22
Category
Article
ISSN
0300-5623

No coin nor oath required. For personal study only.


πŸ“œ SIMILAR VOLUMES


Immunoreactive low-molecular-weight epid
✍ le Coutre, P. ;Bock, S. ;Jakse, G. ;Petrides, P. E. πŸ“‚ Article πŸ“… 1992 πŸ› Springer 🌐 English βš– 405 KB

A specific heterogeneous enzyme-linked immunosorbent assay (ELISA) has been established in order to determine levels of low-molecular-weight epidermal growth factor (EGF) in the urine of patients with renal cell carcinoma who had undergone unilateral radical nephrectomy. Urine specimens, i.e., 20 pr

Epidermal growth factor–related transfor
✍ Ph.D. Lea-Yea Chuang; Juei-Hsiung Tsai; Yun-Chi Yeh; Chun-Chang Chang; Hsing-Wu πŸ“‚ Article πŸ“… 1991 πŸ› John Wiley and Sons 🌐 English βš– 472 KB

To characterize epidermal growth factor-related transforming growth factors in the urine of patients with hepatocellular carcinoma, gel filtration with Bio-Gel P-30 was performed in seven hepatocellular carcinoma patients and seven sex-matched and agematched healthy controls. Distinct profiles of so

Follicular and epidermal alterations in
✍ R. Van Doorn; G. Kirtschig; E. Scheffer; T.J. Stoof; G. Giaccone πŸ“‚ Article πŸ“… 2002 πŸ› John Wiley and Sons 🌐 English βš– 131 KB

We report the cutaneous side-effects of ZD1839 (Iressa), a new anticancer agent that acts by inhibiting epidermal growth factor (EGF) receptor signal transduction. Three patients receiving ZD1839 developed an eruption consisting of follicular papules and pustules in an acneiform distribution as well

Reassessment of the two-site enzyme immu
✍ Yoshifumi Takei; Hisayo Ezawa; Kyozo Hayashi; Masayuki Kurobe πŸ“‚ Article πŸ“… 1995 πŸ› John Wiley and Sons 🌐 English βš– 507 KB

We reassessed the enzyme immunoassay (EIA) system for hEGF previously developed by our laboratory ( C h ChimActa 15651-60, 1985), since it appeared that the reported EIA system detected not only hEGF but also pS2 protein owing to minor contamination by pS2 protein in the hEGF sample used for immuniz